CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,018 | 0 | ||
| 2025-01-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,349 | 128,577 | ||
| 2025-01-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −18,333 | $9.06 | $166K | 877,608 |
| 2024-12-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,017 | $0.54 | $3K | 146,008 |
| 2024-12-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,017 | 5,018 | ||
| 2024-11-11 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +5,017 | $0.54 | $3K | 140,991 |
| 2024-11-11 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +5,026 | $1.08 | $5K | 146,017 |
| 2024-11-11 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −5,026 | $15.00 | $75K | 140,991 |
| 2024-11-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −5,017 | 10,035 | ||
| 2024-11-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −5,026 | 134,926 | ||
| 2024-11-06 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +25,482 | $1.08 | $28K | 161,456 |
| 2024-11-06 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −25,482 | $15.03 | $383K | 135,974 |
| 2024-11-06 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −25,482 | 139,952 | ||
| 2024-10-14 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,352 | $1.08 | $6K | 135,974 |
| 2024-10-14 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,352 | 165,434 | ||
| 2024-10-11 | Levy Adam Scott CFO and Secretary | Sale 10b5-1 | −10,757 | $13.57 | $146K | 236,854 |
| 2024-10-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,017 | $0.54 | $3K | 130,622 |
| 2024-10-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,017 | 15,052 | ||
| 2024-10-11 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −15,271 | $13.52 | $206K | 895,941 |
| 2024-05-22 | Slingsby Brian Taylor Director | Other disposition · Stock Option | −22,000 | 0 |
Page 16 of 17 · 321 trades